Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 04 - 12 entities : Abbvie inc. save search
Insights on the Liver Disease Treatment Global Market to 2027 - by Treatment Type, Disease Type, End-user and Region
Published: 2022-04-12 (Crawled : 21:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 2.6K
|
Health Technology
|
| O: 1.76%
H: 0.35%
C: 0.35%
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: -4.71%
NVSEF | News | $96.0 0.94% 6.88% 52K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: -0.83%
ALPMY | News | $9.49 -0.42% -1.11% 480K
|
Manufacturing
|
| O: 2.3%
H: 0.55%
C: 0.36%
VTRS | News A | $11.36 0.98% 0.97% 3.9M
|
Health Technology
|
| O: 0.37%
H: 2.99%
C: 2.61%
TAK | News | $13.38 0.15% 1.94% 1.7M
|
Health Technology
|
| O: -0.2%
H: 1.83%
C: 1.83%
NVS | News | $97.28 2.27% 1.21% 3.5M
|
Health Technology
|
| O: 0.12%
H: 0.44%
C: 0.17%
GSK | News | $41.24 1.6% -0.58% 2.1M
|
Health Technology
|
| O: -0.24%
H: 0.45%
C: 0.39%
LLY | News | $745.69 1.96% 0.04% 1.4M
|
Health Technology
|
| O: -0.26%
H: 0.33%
C: -1.5%
BMY | $48.99 -0.31% 0.41% 7.1M
|
Health Technology
|
| O: 0.24%
H: 0.53%
C: 0.18%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -1.38%
H: 0.0%
C: -3.67%
ABT | News | $107.59 0.49% 0.33% 3.1M
|
Health Technology
|
| O: -0.7%
H: 1.91%
C: 1.63%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: 0.0%
treatment liver disease market
AbbVie Presents Positive Investigational Navitoclax Combination Data in Phase 2 REFINE Study Suggesting Anti-Fibrosis Activity for Patients with Myelofibrosis
Published: 2022-04-12 (Crawled : 18:00) - biospace.com/
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -0.31%
H: 0.74%
C: -1.18%
positive fibrosis phase 2
Global Pharmaceutical API Manufacturing Market Report 2022-2030: Stringent Regulations for Approval of Pharmaceutical Drugs Restraining Growth
Published: 2022-04-12 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K
|
Health Technology
|
| O: -0.86%
H: 1.21%
C: 1.21%
NVSEF | News | $96.0 0.94% 6.88% 52K
|
Health Technology
|
| O: 0.16%
H: 0.22%
C: 0.22%
NVS | News | $97.28 2.27% 1.21% 3.5M
|
Health Technology
|
| O: -0.48%
H: 0.09%
C: -0.68%
GSK | News | $41.24 1.6% -0.58% 2.1M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
LLY | News | $745.69 1.96% 0.04% 1.4M
|
Health Technology
|
| O: -0.77%
H: 0.99%
C: 0.49%
ALB | News | $114.21 1.71% 0.93% 1.5M
|
Process Industries
|
| O: 1.31%
H: 2.06%
C: -1.76%
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -0.31%
H: 0.74%
C: -1.18%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 4.9M
|
Health Technology
|
| O: -2.32%
H: 0.43%
C: -0.55%
report approval growth market drug
ABBV ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 6, 2022 in the Class Action Filed on Behalf of AbbVie Inc. Shareholders
Published: 2022-04-12 (Crawled : 10:00) - prnewswire.com
ABBV | News | $169.54 0.98% 0.18% 3.2M
|
Health Technology
|
| O: -0.31%
H: 0.74%
C: -1.18%
deadline
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.